Similar articles

• Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy.

  Sharifi M, Lewiecki EM. Sharifi M, et al. Expert Rev Clin Pharmacol. 2014 May;7(3):281-91. doi: 10.1586/17512433.2014.893819. Epub 2014 Mar 3. Expert Rev Clin Pharmacol. 2014. PMID: 24580081 Review.
• Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosis.

  Lewiecki EM. Lewiecki EM. Expert Opin Investig Drugs. 2007 Oct;16(10):1663-72. doi: 10.1517/13543784.16.10.1663. Expert Opin Investig Drugs. 2007. PMID: 17922629 Review.
• Tissue-selective estrogen complexes for postmenopausal women.

  Mirkin S, Komm BS. Mirkin S, et al. Maturitas. 2013 Nov;76(3):213-20. doi: 10.1016/j.maturitas.2013.06.003. Epub 2013 Jul 11. Maturitas. 2013. PMID: 23849704 Review.
• The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.

  Parish SJ, Gillespie JA. Parish SJ, et al. Postgrad Med. 2017 Apr;129(3):340-351. doi: 10.1080/00325481.2017.1281083. Epub 2017 Jan 30. Postgrad Med. 2017. PMID: 28132583 Review.
• Bazedoxifene (Wyeth).

  Gruber C, Gruber D. Gruber C, et al. Curr Opin Investig Drugs. 2004 Oct;5(10):1086-93. Curr Opin Investig Drugs. 2004. PMID: 15535430 Review.